Biotin supplementation in MS clinically valuable but can alter multiple blood test results

Abstract

Get full access to this article

View all access options for this article.

References

Tourbah

Lebrun-Frenay

Edan

. MD1003 (high dose biotin) for the treatment of progressive multiple sclerosis: A randomized, double-blind, placebo-controlled study. Mult Scler 2016; 22: 1719–1731.

Sedel

Papeix

Bellanger

. High doses of biotin in chronic progressive multiple sclerosis: A pilot study. Mult Scler Relat Disord 2015; 4(2): 159–169.

Peyro Saint Paul

Debruyne

Bernard

. Pharmacokinetics and pharmacodynamics of MD1003 (highdose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Drug Metab Toxicol 2016; 12(3): 327–344.

Waghray

Milas

Nyalakonda

. Falsely low parathyroid hormone secondary to biotin interference: A case series. Endocr Pract 2013; 19(3): 451–455.

Wijeratne

Doery

ZX.

Positive and negative interference in immunoassays following biotin ingestion: A pharmacokinetic study. Pathology 2012; 44(7): 674–675.